Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.

about

Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.

Item

http://www.wikidata.org/entity/Q38632428

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Regional citrate anticoagulati ...... c patients with liver failure.

@en

type

Item

label

Regional citrate anticoagulati ...... c patients with liver failure.

@en

prefLabel

Regional citrate anticoagulati ...... c patients with liver failure.

@en

P1476

Regional citrate anticoagulati ...... ic patients with liver failure

@en

P2093

Alyssa A Riley

http://www.w3.org/2001/XMLSchema#string

Keila Rodriguez

http://www.w3.org/2001/XMLSchema#string

Leyat Tal

http://www.w3.org/2001/XMLSchema#string

Mary N Watson

http://www.w3.org/2001/XMLSchema#string

Michael C Braun

http://www.w3.org/2001/XMLSchema#string

Moreshwar S Desai

http://www.w3.org/2001/XMLSchema#string

Poyyapakkam R Srivaths

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?

Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.

Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs.

Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.

Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration

Citrate anticoagulation in pediatric continuous venovenous hemofiltration.

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.

Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study

Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.

Acute renal dysfunction in liver diseases

P304

e0182134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0182134

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ayse Akcan Arikan

Ryan W Himes

P577

2017-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28792509

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

5549692

http://www.w3.org/2001/XMLSchema#string